| International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical … BT Tsuji, JM Pogue, AP Zavascki, M Paul, GL Daikos, A Forrest, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (1 …, 2019 | 714 | 2019 |
| Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram … D Plachouras, M Karvanen, LE Friberg, E Papadomichelakis, ... Antimicrobial agents and chemotherapy 53 (8), 3430-3436, 2009 | 630 | 2009 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 487 | 2017 |
| Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches I Karaiskos, H Giamarellou Expert opinion on pharmacotherapy 15 (10), 1351-1370, 2014 | 406 | 2014 |
| Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill AF Mohamed, I Karaiskos, D Plachouras, M Karvanen, K Pontikis, ... Antimicrobial agents and chemotherapy 56 (8), 4241-4249, 2012 | 309 | 2012 |
| Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing … K Pontikis, I Karaiskos, S Bastani, G Dimopoulos, M Kalogirou, M Katsiari, ... International journal of antimicrobial agents 43 (1), 52-59, 2014 | 290 | 2014 |
| The “old” and the “new” antibiotics for MDR gram-negative pathogens: for whom, when, and how I Karaiskos, S Lagou, K Pontikis, V Rapti, G Poulakou Frontiers in public health 7, 460782, 2019 | 284 | 2019 |
| Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii … I Karaiskos, L Galani, F Baziaka, H Giamarellou International journal of antimicrobial agents 41 (6), 499-508, 2013 | 203 | 2013 |
| Management of KPC-producing Klebsiella pneumoniae infections M Bassetti, DR Giacobbe, H Giamarellou, C Viscoli, GL Daikos, ... Clinical Microbiology and Infection 24 (2), 133-144, 2018 | 178 | 2018 |
| Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae H Giamarellou, L Galani, F Baziaka, I Karaiskos Antimicrobial agents and chemotherapy 57 (5), 2388-2390, 2013 | 173 | 2013 |
| Colistin population pharmacokinetics after application of a loading dose of 9 MU colistin methanesulfonate in critically ill patients I Karaiskos, LE Friberg, K Pontikis, K Ioannidis, V Tsagkari, L Galani, ... Antimicrobial agents and chemotherapy 59 (12), 7240-7248, 2015 | 130 | 2015 |
| Colistin: still a lifesaver for the 21st century? I Karaiskos, M Souli, I Galani, H Giamarellou Expert opinion on drug metabolism & toxicology 13 (1), 59-71, 2017 | 124 | 2017 |
| Carbapenem-sparing strategies for ESBL producers: when and how I Karaiskos, H Giamarellou Antibiotics 9 (2), 61, 2020 | 121 | 2020 |
| A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... Mayo Clinic Proceedings 91 (10), 1362-1371, 2016 | 103 | 2016 |
| Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration M Karvanen, D Plachouras, LE Friberg, E Paramythiotou, ... Antimicrobial agents and chemotherapy 57 (1), 668-671, 2013 | 98 | 2013 |
| Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens I Karaiskos, I Galani, M Souli, H Giamarellou Expert opinion on drug metabolism & toxicology 15 (2), 133-149, 2019 | 94 | 2019 |
| Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis AP Georgopoulou, A Savva, EJ Giamarellos-Bourboulis, M Georgitsi, ... Journal of critical care 26 (3), 331. e1-331. e7, 2011 | 92 | 2011 |
| Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 I Galani, I Karaiskos, I Karantani, V Papoutsaki, S Maraki, V Papaioannou, ... Eurosurveillance 23 (31), 1700775, 2018 | 88 | 2018 |
| Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance I Galani, K Nafplioti, P Adamou, I Karaiskos, H Giamarellou, M Souli BMC infectious diseases 19, 1-12, 2019 | 85 | 2019 |
| Population pharmacokinetics of fosfomycin in critically ill patients SL Parker, F Frantzeskaki, SC Wallis, C Diakaki, H Giamarellou, ... Antimicrobial agents and chemotherapy 59 (10), 6471-6476, 2015 | 84 | 2015 |
